IL99468A - (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them - Google Patents

(3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL99468A
IL99468A IL99468A IL9946891A IL99468A IL 99468 A IL99468 A IL 99468A IL 99468 A IL99468 A IL 99468A IL 9946891 A IL9946891 A IL 9946891A IL 99468 A IL99468 A IL 99468A
Authority
IL
Israel
Prior art keywords
group
preparation
pharmaceutical compositions
formula
alkyl
Prior art date
Application number
IL99468A
Other languages
English (en)
Other versions
IL99468A0 (en
Inventor
Raphael Mechoulam
Aviva Breuer
William Devane
Sunmer H Burstein
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL99468A priority Critical patent/IL99468A/xx
Publication of IL99468A0 publication Critical patent/IL99468A0/xx
Priority to AU26787/92A priority patent/AU664204B2/en
Priority to AT92920778T priority patent/ATE187721T1/de
Priority to US08/190,089 priority patent/US5635530A/en
Priority to DE69230446T priority patent/DE69230446T2/de
Priority to PCT/US1992/007718 priority patent/WO1993005031A1/en
Priority to JP50551793A priority patent/JP3298881B2/ja
Priority to CA002118929A priority patent/CA2118929C/en
Priority to EP92920778A priority patent/EP0642504B1/de
Priority to US08/192,923 priority patent/US5538993A/en
Publication of IL99468A publication Critical patent/IL99468A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL99468A 1991-09-12 1991-09-12 (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them IL99468A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL99468A IL99468A (en) 1991-09-12 1991-09-12 (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
EP92920778A EP0642504B1 (de) 1991-09-12 1992-09-11 (3s, 4s)-delta-6-tetrahydrocannabinol-7-säuren und ihre derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69230446T DE69230446T2 (de) 1991-09-12 1992-09-11 (3s, 4s)-delta-6-tetrahydrocannabinol-7-säuren und ihre derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
AT92920778T ATE187721T1 (de) 1991-09-12 1992-09-11 (3s, 4s)-delta-6-tetrahydrocannabinol-7-säuren und ihre derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
US08/190,089 US5635530A (en) 1991-09-12 1992-09-11 (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them
AU26787/92A AU664204B2 (en) 1991-09-12 1992-09-11 (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
PCT/US1992/007718 WO1993005031A1 (en) 1991-09-12 1992-09-11 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
JP50551793A JP3298881B2 (ja) 1991-09-12 1992-09-11 （３ｓ，４ｓ）−デルタ−６−テトラヒドロカンナビノール−７−酸及びそれらの誘導体並びにそれらの合成方法並びにそれらを含む医薬組成物
CA002118929A CA2118929C (en) 1991-09-12 1992-09-11 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
US08/192,923 US5538993A (en) 1991-09-12 1994-02-07 Certain tetrahydrocannabinol-7-oic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL99468A IL99468A (en) 1991-09-12 1991-09-12 (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
IL99468A0 IL99468A0 (en) 1992-08-18
IL99468A true IL99468A (en) 1997-09-30

Family

ID=11062883

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99468A IL99468A (en) 1991-09-12 1991-09-12 (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them

Country Status (8)

Country Link
EP (1) EP0642504B1 (de)
JP (1) JP3298881B2 (de)
AT (1) ATE187721T1 (de)
AU (1) AU664204B2 (de)
CA (1) CA2118929C (de)
DE (1) DE69230446T2 (de)
IL (1) IL99468A (de)
WO (1) WO1993005031A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338753A (en) * 1992-07-14 1994-08-16 Sumner H. Burstein (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
US6162829A (en) * 1997-10-17 2000-12-19 Atlantic Pharmaceuticals, Inc. (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
EP1071419B1 (de) 1998-04-21 2007-07-25 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Cannabinoiden als antioxidantien und neuroschützende mittel
AU2002319422C1 (en) * 2001-07-10 2008-05-01 Norton Healthcare Limited Aerosol formulations of delta8 tetrahydrocannabinol
GB0202385D0 (en) * 2002-02-01 2002-03-20 Gw Pharma Ltd Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
EP1482917B1 (de) * 2002-02-01 2019-05-08 GW Pharma Limited Zusammensetzungen mit cannabidiolsäure zur behandlung von übelkeit, erbrechen, emesis, reisekrankheit oder ähnlichen zuständen
IL148244A0 (en) 2002-02-19 2002-09-12 Yissum Res Dev Co Anti-nausea and anti-vomiting activity of cannabidiol compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5144030A (en) * 1987-02-17 1992-09-01 Abbott Laboratories Fluorescene polarization immunoassay for tetrahydrocannabinoids
US4973603A (en) * 1988-06-16 1990-11-27 Sumner Burstein Platelet activating factor antagonist and methods of use therefor
US5036014A (en) * 1989-01-31 1991-07-30 Elsohly Mahmoud A Deuterated cannabinoids as standards for the analysis of tetrahydrocannabinol and its metabolites in biological fluids

Also Published As

Publication number Publication date
EP0642504B1 (de) 1999-12-15
CA2118929A1 (en) 1993-03-18
ATE187721T1 (de) 2000-01-15
AU2678792A (en) 1993-04-05
EP0642504A4 (de) 1994-08-22
JP3298881B2 (ja) 2002-07-08
IL99468A0 (en) 1992-08-18
EP0642504A1 (de) 1995-03-15
DE69230446D1 (de) 2000-01-20
JPH07505119A (ja) 1995-06-08
CA2118929C (en) 2004-04-27
WO1993005031A1 (en) 1993-03-18
DE69230446T2 (de) 2000-04-13
AU664204B2 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
AU1463195A (en) Substituted aromatic compounds as c.amp phosphodiesterase- and tnf-inhibitors
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
CA2140368A1 (en) (3r,4r)-.delta.6-tetrahydrocannabinol-7-oic acids
AU560980B2 (en) New vitro alphatic compounds
IL99468A0 (en) (3s,4s)-delta-6-tetrahydrocannabinol-7-ioc acids and derivatives thereof,processes for their preparation and pharmaceutical compositions containing them
EP0149487A3 (en) New cephem compounds, process for preparation thereof and pharmaceutical compositions containing them
PH24176A (en) New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same
EP0605474A4 (de)
AU631262B2 (en) Nmda-blocking pharmaceutical compositions
TW366348B (en) Novel trans apovincaminic acid ester derivatives, pharmaceutical composition containing same, and their preparation processes
IL70552A (en) Aminoethoxybenzyl alcohol derivatives,their preparation and pharmaceutical compositions containing them
DE3063105D1 (en) Clavulanic acid derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees